Cases in Precision Oncology: Highlights from the 2025 ClinGen Somatic Cancer and VICC Virtual Molecular Tumor Board Case Series
This CME Case Series reflects the work of molecular tumor boards by featuring an interdisciplinary discussion of cases that are subject to comprehensive molecular characterization using a variety of advanced technologies. The molecular characterization of tumor samples ranges from methods on the genomic level to recent advances in proteomics. The field is advancing rapidly, and more and more approaches will translate from basic research to clinical care. In this session, we will summarize the variety of methods described in previous virtual molecular tumor boards and highlight the most interesting cases from 2025. In addition, we will give an outlook on topics to come in 2026.